Bhavnagri Veer 4
4 · Allogene Therapeutics, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2021-05-18$2.27/sh+5,000$11,350→ 426,353 total - Sale
Common Stock
2021-05-18$30.00/sh−5,000$150,000→ 421,353 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-18−5,000→ 132,300 totalExercise: $2.27Exp: 2028-06-25→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020.
- [F2]25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.